rs171649

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000517412.2(PIK3R1):​n.1463G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.362 in 1,597,208 control chromosomes in the GnomAD database, including 109,233 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 8116 hom., cov: 31)
Exomes 𝑓: 0.37 ( 101117 hom. )

Consequence

PIK3R1
ENST00000517412.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.138

Publications

23 publications found
Variant links:
Genes affected
PIK3R1 (HGNC:8979): (phosphoinositide-3-kinase regulatory subunit 1) Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]
PIK3R1 Gene-Disease associations (from GenCC):
  • immunodeficiency 36 with lymphoproliferation
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • SHORT syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • agammaglobulinemia 7, autosomal recessive
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal agammaglobulinemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 5-68273918-G-A is Benign according to our data. Variant chr5-68273918-G-A is described in ClinVar as Benign. ClinVar VariationId is 1271646.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.379 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIK3R1NM_181523.3 linkc.428-21G>A intron_variant Intron 3 of 15 ENST00000521381.6 NP_852664.1 P27986-1A0A2X0SFG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIK3R1ENST00000521381.6 linkc.428-21G>A intron_variant Intron 3 of 15 1 NM_181523.3 ENSP00000428056.1 P27986-1

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
44694
AN:
151964
Hom.:
8120
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0735
Gnomad AMI
AF:
0.381
Gnomad AMR
AF:
0.355
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.361
Gnomad SAS
AF:
0.377
Gnomad FIN
AF:
0.399
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.302
GnomAD2 exomes
AF:
0.363
AC:
91016
AN:
250972
AF XY:
0.367
show subpopulations
Gnomad AFR exome
AF:
0.0698
Gnomad AMR exome
AF:
0.399
Gnomad ASJ exome
AF:
0.352
Gnomad EAS exome
AF:
0.348
Gnomad FIN exome
AF:
0.405
Gnomad NFE exome
AF:
0.385
Gnomad OTH exome
AF:
0.365
GnomAD4 exome
AF:
0.370
AC:
533983
AN:
1445124
Hom.:
101117
Cov.:
28
AF XY:
0.371
AC XY:
267106
AN XY:
720022
show subpopulations
African (AFR)
AF:
0.0612
AC:
2025
AN:
33098
American (AMR)
AF:
0.395
AC:
17653
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
9180
AN:
26012
East Asian (EAS)
AF:
0.380
AC:
15043
AN:
39604
South Asian (SAS)
AF:
0.376
AC:
32356
AN:
85946
European-Finnish (FIN)
AF:
0.408
AC:
21789
AN:
53360
Middle Eastern (MID)
AF:
0.300
AC:
1721
AN:
5740
European-Non Finnish (NFE)
AF:
0.377
AC:
413171
AN:
1096836
Other (OTH)
AF:
0.352
AC:
21045
AN:
59830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
16083
32167
48250
64334
80417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12742
25484
38226
50968
63710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.294
AC:
44679
AN:
152084
Hom.:
8116
Cov.:
31
AF XY:
0.297
AC XY:
22060
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.0733
AC:
3043
AN:
41512
American (AMR)
AF:
0.355
AC:
5415
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1224
AN:
3466
East Asian (EAS)
AF:
0.361
AC:
1866
AN:
5164
South Asian (SAS)
AF:
0.376
AC:
1812
AN:
4820
European-Finnish (FIN)
AF:
0.399
AC:
4211
AN:
10552
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.383
AC:
26033
AN:
67984
Other (OTH)
AF:
0.303
AC:
639
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1465
2929
4394
5858
7323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.343
Hom.:
2334
Bravo
AF:
0.280
Asia WGS
AF:
0.338
AC:
1174
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunodeficiency 36 with lymphoproliferation Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 61% of patients studied by a panel of primary immunodeficiencies. Number of patients: 59. Only high quality variants are reported. -

Agammaglobulinemia 7, autosomal recessive Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SHORT syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
7.9
DANN
Benign
0.90
PhyloP100
-0.14
BranchPoint Hunter
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs171649; hg19: chr5-67569746; COSMIC: COSV57122901; COSMIC: COSV57122901; API